DENVER — Children with amblyopia treated with an at-home device experienced improvement in visual acuity and binocularity, according to a study presented at the Association for Research in Vision and Ophthalmology meeting.
Oren Yehezkel, PhD, reported data from a pivotal randomized controlled trial that compared the CureSight (NovaSight) eye tracking-based device to patching in children with amblyopia.
“Other studies have shown that the compliance for patching is about 50%,” he told Healio/OSN. “Children tend not to like the patch. This [device] gives them a chance to